Blog

Targeting multi-drug resistant bacteria with novel Cannabis compounds recovered directly from deep mining the genome With bioclinical partners AMPLY located a series of novel antimicrobial

AMPLY can process publicly available digital biological data. But it can also process unique data collected at remote sites. Members of the AMPLY team travelled

AMPLY has analysed genomes, transcriptomes and metagenomes of a variety of ruminal animals with a view to generating a holistic library of ruminally expressed compounds